E-LIB Suche - Ergebnisse für: Lopez-Miranda, Elena - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 V..:

Saavedra, Cristina ; Vallejo, Alejandro ; Longo, Federico...
Cancers. 15 (2023) 7 - p. 2000 , 2023

Link: https://doi.org/10.3390/..

2

A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patie..:

Hanna, Glenn J. ; Stathis, Anastasios ; Lopez-Miranda, Elena...
Cancer Research Communications. 3 (2023) 9 - p. 1853-1861 , 2023

Link: https://doi.org/10.1158/..

3

A single-arm study design with non-inferiority and superior..:

Sampayo-Cordero, Miguel ; Miguel-Huguet, Bernat ; Malfettone, Andrea...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Lutein..:

Jhaveri, Komal L. ; Bellet, Meritxell ; Turner, Nicholas C....
Clinical Cancer Research. 30 (2023) 4 - p. 754-766 , 2023

Link: https://doi.org/10.1158/..

5

Challenging Endocrine Sensitivity of Hormone Receptor-Posit..:

López González, Ana ; Del Barco Berrón, Sonia ; Grau, Isabel...
Cancers. 14 (2022) 23 - p. 5880 , 2022

Link: https://doi.org/10.3390/..

6

Pembrolizumab plus eribulin in hormone-receptor–positive, H..:

Pérez-García, José M. ; Llombart-Cussac, Antonio ; Gion, María...
European Journal of Cancer. 148 (2021) - p. 382-394 , 2021

Link: https://doi.org/10.1016/..

7

Pembrolizumab Plus Gemcitabine in the Subset of Triple-Nega..:

de la Cruz-Merino, Luis ; Gion, María ; Cruz-Jurado, Josefina...
Cancers. 13 (2021) 21 - p. 5432 , 2021

Link: https://doi.org/10.3390/..

8

Strongyloides in bronchoalveolar lavage fluid: practical im..:

Norman, Francesca F ; Chamorro, Sandra ; Braojos, Francisco...
Journal of Travel Medicine. 29 (2021) 1 - p. , 2021

Link: https://doi.org/10.1093/..

9

Inclusion of non-inferiority analysis in superiority-based ..:

Sampayo-Cordero, Miguel ; Miguel-Huguet, Bernat ; Pérez-García, José...
Contemporary Clinical Trials Communications. 20 (2020) - p. 100678 , 2020

Link: https://doi.org/10.1016/..

10

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubi..:

López-Miranda, Elena ; Pérez-García, José Manuel ; Di Cosimo, Serena...
Cancers. 12 (2020) 12 - p. 3509 , 2020

Link: https://doi.org/10.3390/..

11

High Frequency of ERBB2 Activating Mutations in Invasive Lo..:

Rosa-Rosa, Juan Manuel ; Caniego-Casas, Tamara ; Leskela, Susanna...
Cancers. 11 (2019) 1 - p. 74 , 2019

Link: https://doi.org/10.3390/..

12

Maintained complete response to talazoparib in a BRCA-2 mut..:

Albarrán, Víctor ; Chamorro, Jesús ; Pozas, Javier...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

13

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 V..:

Saavedra, Cristina ; Vallejo, Alejandro ; Longo, Federico...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093435/. , 2023

Link: http://www.ncbi.nlm.nih...

14

A single-arm study design with non-inferiority and superior..:

Sampayo-Cordero, Miguel ; Miguel-Huguet, Bernat ; Malfettone, Andrea...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368397/. , 2023

Link: http://www.ncbi.nlm.nih...

15

A single-arm study design with non-inferiority and superior..:

Sampayo-Cordero, Miguel ; Miguel-Huguet, Bernat ; Malfettone, Andrea...
Frontiers in Oncology;13. , 2023

Link: https://hdl.handle.net/1..

1-15